Based on the above, a potential cardioprotective role of myostatin can be ascribed to the suppression of metabolic reprograming towards the fetal metabolic pattern that occurs during cardiac hypertrophy and maintenance of a mature aerobic energy metabolism. Here, MSTN is linked to cardiac hypertrophy.